WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it...

23

Transcript of WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it...

Page 1: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 2: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 3: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 4: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 5: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 6: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 7: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 8: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 9: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 10: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 11: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 12: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 13: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 14: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 15: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 16: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 17: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 18: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 19: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 20: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 21: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 22: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products
Page 23: WORDSWORTH-20131028124045...FDA has clearly argued against unique INNS for biosimilars when it stated: "INNs should not be used to imply pharmacologic interchangeability of products

Parisa Inns Pichitmarn

Parisa Inns Pichitmarn

williams wordsworth

williams wordsworth

Mosin Nagant Parts Interchangeability

Mosin Nagant Parts Interchangeability

Prod Interchangeability TCS

Prod Interchangeability TCS

NATO Small Arms Ammunition Interchangeability … Small Arms Ammunition Interchangeability via Direct ... Inspection NATO ... Small Arms Ammunition Interchangeability.

NATO Small Arms Ammunition Interchangeability … Small Arms Ammunition Interchangeability via Direct ... Inspection NATO ... Small Arms Ammunition Interchangeability.

Inns - Romance 2012

Inns - Romance 2012

Interchangeability With a Reference Product · interchangeability at each step of the development process. (Draft Guidance at 5) This general approach toward demonstrating interchangeability

Interchangeability With a Reference Product · interchangeability at each step of the development process. (Draft Guidance at 5) This general approach toward demonstrating interchangeability

22. wordsworth

22. wordsworth

Interchangeability iiit

Interchangeability iiit

U.S. Navy: Interchangeability & Substitutability

U.S. Navy: Interchangeability & Substitutability

Lawyers Inns Proposal

Lawyers Inns Proposal

Preface wordsworth

Preface wordsworth

Wordsworth 5

Wordsworth 5

Attachments and Interchangeability List

Attachments and Interchangeability List

Wordsworth 2020

Wordsworth 2020

Enterprise Inns plc

Enterprise Inns plc

Biosimilar Interchangeability, Educaon AMCP Urges FDA to ... · Biosimilar Interchangeability, Educaon AMCP this week called on the FDA to issue final guidance on interchangeability

Biosimilar Interchangeability, Educaon AMCP Urges FDA to ... · Biosimilar Interchangeability, Educaon AMCP this week called on the FDA to issue final guidance on interchangeability

American Historic Inns

American Historic Inns

THE 4 INNS

THE 4 INNS

Wt pattern mono.tif Beyond Words€¦ · 10 Wordsworth Trust: beyond words Our brand The logo Typography Colour The Wordsworth Trust pattern Discover Wordsworth Discover Wordsworth

Wt pattern mono.tif Beyond Words€¦ · 10 Wordsworth Trust: beyond words Our brand The logo Typography Colour The Wordsworth Trust pattern Discover Wordsworth Discover Wordsworth